Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
Doan T, Hinterwirth A, Arzika AM, Worden L, Chen C, Zhong L, Oldenburg CE, Keenan JD, Lietman TM. Doan T, et al. Among authors: oldenburg ce. Clin Infect Dis. 2020 Nov 19;71(16):2282-2284. doi: 10.1093/cid/ciaa606. Clin Infect Dis. 2020. PMID: 32426812 Free PMC article. Clinical Trial.
Microbiological cure times in acanthamoeba keratitis.
Oldenburg CE, Keenan JD, Cevallos V, Chan MF, Acharya NR, Gaynor BD, McLeod SD, Esterberg EJ, Porco TC, Lietman TM. Oldenburg CE, et al. Eye (Lond). 2011 Sep;25(9):1155-60. doi: 10.1038/eye.2011.126. Epub 2011 Jun 3. Eye (Lond). 2011. PMID: 21637300 Free PMC article.
Gender differences in re-epithelialisation time in fungal corneal ulcers.
Krishnan T, Prajna NV, Gronert K, Oldenburg CE, Ray KJ, Keenan JD, Lietman TM, Acharya NR. Krishnan T, et al. Among authors: oldenburg ce. Br J Ophthalmol. 2012 Jan;96(1):137-8. doi: 10.1136/bjophthalmol-2011-300441. Epub 2011 Oct 6. Br J Ophthalmol. 2012. PMID: 21979901 Free PMC article. Clinical Trial. No abstract available.
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Sy A, et al. Among authors: oldenburg ce. Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840. Invest Ophthalmol Vis Sci. 2012. PMID: 22159005 Free PMC article. Clinical Trial.
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Lalitha P, et al. Among authors: oldenburg ce. Clin Infect Dis. 2012 May;54(10):1381-7. doi: 10.1093/cid/cis189. Epub 2012 Mar 23. Clin Infect Dis. 2012. PMID: 22447793 Free PMC article.
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Prajna VN, Lalitha PS, Mascarenhas J, Krishnan T, Srinivasan M, Vaitilingam CM, Oldenburg CE, Sy A, Keenan JD, Porco TC, Acharya NR, Lietman TM. Prajna VN, et al. Among authors: oldenburg ce. Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21. Br J Ophthalmol. 2012. PMID: 22914503 Free PMC article. No abstract available.
Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. See CW, et al. Among authors: oldenburg ce. Ophthalmic Epidemiol. 2012 Dec;19(6):407-13. doi: 10.3109/09286586.2012.735332. Ophthalmic Epidemiol. 2012. PMID: 23171211 Free PMC article. Clinical Trial.
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM. Ray KJ, et al. Among authors: oldenburg ce. JAMA Ophthalmol. 2013 Mar;131(3):310-3. doi: 10.1001/jamaophthalmol.2013.1718. JAMA Ophthalmol. 2013. PMID: 23307105 Free PMC article. Clinical Trial.
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Oldenburg CE, et al. Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1522-6. doi: 10.1167/iovs.12-11246. Invest Ophthalmol Vis Sci. 2013. PMID: 23385795 Free PMC article. Clinical Trial.
249 results